Kopran Share Price

₹ 242.21

+₹3.16 (1.32%)

Last updated 02 Nov, 2026, 15:54 IST

NSE: KOPRAN

Kopran Share Price Today

As of 2 Nov 2026, Kopran share price is ₹242.21. The stock opened at ₹240.50, compared to its previous close of ₹239.05. During today's trading session, Kopran share price moved in the range of ₹239.00 to ₹246.27, with an average price of ₹242.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹107.00 and a high of ₹295.83. On the performance front, Kopran share price has increased by 45.20% over the last six months and is up 44.20% on a year-on-year basis.

₹239.00

1.32% up today

₹246.27

1D LOW

1D HIGH

Kopran Stock Insights

Latest Earning

Op Profit TrendDown by 65.29% QoQ

Latest Earning

Net Profit TrendDown by 64.49% QoQ

Latest Earning

Revenue TrendUp by 7.61% YoY

Stock Performance

OutperformingBeat Nifty by 30.6 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 5.85%

Shareholding Pattern

DIIDII increased stake by 8.33%

Shareholding Pattern

FIIFII increased stake by 76.32%

Kopran Stock Insights

Latest Earning

Op Profit TrendDown by 65.29% QoQ

Latest Earning

Net Profit TrendDown by 64.49% QoQ

Latest Earning

Revenue TrendUp by 7.61% YoY

Stock Performance

OutperformingBeat Nifty by 30.6 % in last 3 month

Shareholding Pattern

PromoterPromoter decreased stake by 5.85%

Shareholding Pattern

DIIDII increased stake by 8.33%

Shareholding Pattern

FIIFII increased stake by 76.32%

Kopran stock performance
Open	₹240.50
High	₹246.27
Low	₹239.00
Prev. close	₹239.05

Kopran trading activity
Volume	2,22,395
Average traded price	₹242.06
Last traded time	03:54:45 02 Nov
Last traded quantity	1,500

₹191.24₹286.86

Circuit Low

Circuit High

₹107.00₹295.83

52-Week Low

52-Week High

Circuit

₹191.24

₹286.86

52-week

₹107.00

₹295.83

Mkt Cap Cr

1,156.44

P/E

46.29

P/B

2.18

ROA

2.75%

ROE

4.85%

ROCE

6.56%

Quick Ratio

1.04

EV/EBITDA

20.49

Mkt Cap Cr

1,156.44

P/E

46.29

P/B

2.18

ROA

2.75%

ROE

4.85%

ROCE

6.56%

Quick Ratio

1.04

EV/EBITDA

20.49

Based on fundamentals, this stock's

Performance

Very Poor

Kopran has not beaten FD return of 7%

Valuation

Overvalued

Kopran appears overvalued compared to its peers

Earnings

Poor

Kopran earnings have been degrowing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Kopran Company Background

ISIN

INE082A01010

Sector Market Cap

₹ 1,156.44 Cr

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Kopran Financial Highlights

Revenue: Kopran reported revenue of ₹681.77 crore in FY26 vs ₹633.58 crore in FY25. It showed an increase of 7.61% on a yearly basis.
Operating Profit: Kopran reported an operating profit of ₹34.36 crore in FY26 vs ₹51.95 crore in FY25. It showed a decrease of 33.86% on a year-on-year basis.
Net Profit: Kopran reported a net profit of ₹25.73 crore in FY26 vs ₹38.55 crore in FY25. It showed a decrease of 33.26% on a yearly basis.

Kopran Quarterly Result Highlights

Kopran reported revenue of ₹156.04 crore in Jun 2026, compared with ₹234.11 crore in Mar 2026, representing a decrease of 33.35% on a quarter-on-quarter (QoQ) basis.
Kopran reported an operating profit of ₹8.80 crore in Jun 2026, compared with ₹25.35 crore in Mar 2026, representing a decrease of 65.29% on a quarter-on-quarter (QoQ) basis.
Kopran reported a profit of ₹6.70 crore in Jun 2026, compared with ₹18.87 crore in Mar 2026, reflecting a decrease of 64.49% on a QoQ basis.
The earnings per share (EPS) of Kopran stood at ₹5.33 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

41.82%

FII

0.91%

Other DII

0.00%

Retail and other

57.27%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.36%
Mar 2026	0.57%
Jun 2026	0.51%
Sep 2026	0.91%

Kopran Investment Returns

1 day

-5.14%

1 week

-2.94%

1 month

-14.11%

1 year

+44.20%

3 years

+5.59%

5 years

+21.47%

Kopran Share Price History

Kopran share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
30 Oct 26	₹253.80 / ₹239.05	-5.14%
29 Oct 26	₹253.70 / ₹252.00	-0.18%
28 Oct 26	₹249.15 / ₹252.45	+1.26%
27 Oct 26	₹250.50 / ₹249.30	+0.04%
26 Oct 26	₹243.30 / ₹249.20	+1.18%
23 Oct 26	₹263.85 / ₹246.30	-5.87%
22 Oct 26	₹264.00 / ₹261.65	-0.91%
21 Oct 26	₹279.00 / ₹264.05	-5.10%
19 Oct 26	₹270.00 / ₹278.25	+2.62%
16 Oct 26	₹272.80 / ₹271.15	-1.00%

Kopran Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹681.42	₹629.60	₹614.59	₹550.99
Other Income	₹0.35	₹3.98	₹14.61	₹3.07
Total Revenue	₹681.77	₹633.59	₹629.20	₹554.05
Total Expenses	₹647.41	₹581.64	₹561.66	₹517.99
Profit Before Tax	₹34.36	₹51.95	₹67.54	₹36.07
Tax	₹8.63	₹13.40	₹16.59	₹8.83
Profit After Tax	₹25.73	₹38.55	₹50.96	₹27.23
EPS - Basic	₹5.33	₹7.99	₹10.57	₹5.65
EPS - Diluted	₹5.33	₹7.99	₹10.57	₹5.65

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹51.95	₹67.54	₹36.07	₹81.78
Income before WC changes	₹76.75	₹88.50	₹52.36	₹95.60
Change in Assets	-₹39.13	-₹37.47	-₹73.13	-₹89.48
Change in Liabilities	₹17.57	₹6.55	₹67.58	-₹21.33
Change in WC	-₹21.56	-₹30.91	-₹5.55	-₹110.81
Cash flow from Operations	₹41.94	₹43.26	₹34.02	-₹33.48
Cash flow from Investing	-₹56.43	-₹43.55	-₹12.65	-₹84.42
Cash flow from Financing	₹25.87	₹0.99	-₹19.84	₹122.82
Total Cash Flow	₹11.38	₹0.69	₹1.53	₹4.93
Cash (Start of the year)	₹8.09	₹7.40	₹5.87	₹0.94
Cash (End of the year)	₹19.47	₹8.09	₹7.40	₹5.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹385.19	₹334.26	₹289.22	₹250.63
Current Assets	₹523.18	₹509.75	₹454.03	₹399.07
Total Assets	₹908.36	₹844.01	₹743.25	₹649.70
Current Liabilities	₹346.18	₹288.97	₹218.53	₹176.97
Net Current Asset	₹177.00	₹220.78	₹235.50	₹222.10
Non-Current Liabilities	₹31.90	₹36.70	₹33.47	₹33.48
Equity Capital	₹530.28	₹518.35	₹491.25	₹439.25
Total Equity & Liabilities	₹908.36	₹844.01	₹743.25	₹649.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹305.65	₹271.01	₹337.46	₹273.09
Other Income	₹2.00	₹5.90	₹16.71	₹16.09
Total Revenue	₹307.65	₹276.91	₹354.17	₹289.18
Total Expenses	₹267.25	₹241.12	₹309.65	₹252.27
Profit Before Tax	₹40.39	₹35.79	₹44.52	₹36.92
Tax	₹9.99	₹8.94	₹9.88	₹5.66
Profit After Tax	₹30.40	₹26.86	₹34.64	₹31.25
EPS - Basic	₹6.30	₹5.57	₹7.18	₹6.48
EPS - Diluted	₹6.30	₹5.57	₹7.17	₹6.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹35.79	₹44.52	₹36.92	₹16.16
Income before WC changes	₹42.38	₹47.20	₹27.87	₹20.33
Change in Assets	-₹5.26	₹8.36	-₹39.24	-₹41.63
Change in Liabilities	-₹3.73	-₹10.77	₹34.55	-₹12.90
Change in WC	-₹8.99	-₹2.41	-₹4.68	-₹54.53
Cash flow from Operations	₹23.30	₹34.96	₹16.87	-₹37.80
Cash flow from Investing	-₹15.41	-₹6.27	₹10.05	-₹100.26
Cash flow from Financing	₹5.64	-₹24.08	-₹26.13	₹137.99
Total Cash Flow	₹13.53	₹4.61	₹0.79	-₹0.07
Cash (Start of the year)	₹5.65	₹1.04	₹0.25	₹0.32
Cash (End of the year)	₹19.18	₹5.65	₹1.04	₹0.25

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹365.65	₹337.44	₹323.17	₹315.54
Current Assets	₹240.24	₹209.05	₹187.70	₹190.41
Total Assets	₹605.89	₹546.48	₹510.88	₹505.95
Current Liabilities	₹146.94	₹103.33	₹84.54	₹100.88
Net Current Asset	₹93.29	₹105.72	₹103.16	₹89.53
Non-Current Liabilities	₹11.12	₹11.72	₹9.47	₹9.48
Equity Capital	₹447.83	₹431.44	₹416.87	₹395.59
Total Equity & Liabilities	₹605.89	₹546.48	₹510.88	₹505.95